Clene (CLNN) Defensive Interval Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLNN Clene Inc CLNN
34 GF Score
Price $4.14
GF Value $0.87
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Clene Defensive Interval Ratio?

CLNN
34GF Score
Clene Inc CLNN
Defensive Interval Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clene (CLNN) Overvalued in 2026?

Based on GuruFocus' analysis, Clene stock appears to be overvalued. The current stock price of $4.14 is trading 375.9% above its estimated GF Value™ of $0.87. GuruFocus considers Clene to be Significantly Overvalued.

Key valuation signals for CLNN:

  • Defensive Interval Ratio:
  • GF Value™: $0.87 vs. price of $4.14 (375.9% above fair value)
  • GF Score™: 34/100 with 8 warning signs

No single metric tells the full story. See the CLNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clene Business Description

Other Exchanges 84C0:Germany
Address 6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
34GF Score

Get the complete analysis for CLNN

Defensive Interval Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.14
Price
$0.87
GF Value